Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
6 Patents
#109 in Gyeonggi-do
#1,619 in South Korea
Nkmax Co., Ltd.
Forward Citations = 19
13 inventors:
Nkmax Co., Ltd.
EPO Patents = 2
Trademarks = 8
Forward Citations = 19
Loading Chart...
Loading Chart...
13 inventors (with patents filed for the assignee):
Yong-Hee Rhee (4 out of 4 patents)
Yong Man Kim (3 out of 3 patents)
Sang Woo Park (3 out of 9 patents)
4. Jae Seob Jung (3 out of 3 patents)
5. Seon Ah Lim (1 out of 6 patents)
6. Tae-Gyun Kim (1 out of 33 patents)
7. Cassian Yee (1 out of 3 patents)
8. Sang-min Oh (1 out of 1 patent)
9. Jong Sun Kim (1 out of 23 patents)
10. Jae Myun Lee (1 out of 2 patents)
11. Sang Woo Park (1 out of 33 patents)
12. Kyung Mi Lee (1 out of 2 patents)
13. Joo Chun Yoon (1 out of 2 patents)
14. Jae Ho Cheong (8 patents)
15. Eun Sung Park (1 patent)
6 patents:
2. 12098388 - Method of producing natural killer cells and composition for treating cancer (2024-09-24),
3. 11504396 - Pharmaceutical composition and methods comprising immune cells and ponatinib (2022-11-22),
4. 11066644 - Method of producing natural killer cells and composition for treating cancer (2021-07-20),
Company Overview
Nkmax Co., Ltd. is a leading provider of innovative solutions in the field of biotechnology. With a focus on research and development, Nkmax is dedicated to improving the lives of patients through the creation of cutting-edge products and therapies. Through strategic partnerships with industry leaders, Nkmax continues to push the boundaries of what is possible in healthcare.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nkmax Co., Ltd.. Retrieved from https://idiyas.com/company/nkmax-company
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]